Kezar Life Sciences Inc. (NASDAQ: KZR)
$7.5450
-0.0750 ( +0.60% ) 21.4K
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Market Data
Open
$7.5450
Previous close
$7.6200
Volume
21.4K
Market cap
$55.38M
Day range
$7.3100 - $7.6200
52 week range
$5.2020 - $11.3500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 12 | Dec 04, 2023 |
| 10-q | Quarterly Reports | 79 | Nov 13, 2023 |
| 8-k | 8K-related | 13 | Nov 13, 2023 |
| 4 | Insider transactions | 1 | Nov 09, 2023 |